Juvenescence
2026-09-03juvlabs.com
Overview
What they do
Juvenescence is a biotechnology company focused on extending healthy lifespan by developing innovative medicines that target core aging mechanisms. Its work includes proprietary small-molecule therapeutics aimed at preventing or treating age-related diseases, such as CD38 inhibitors developed in collaboration with leading aging research institutes.
juvlabs.com
What they look for
Our portfolio companies represent strategic investments across a diverse array of technologies focused on increasing healthy lifespan. These span platform technologies, cell therapies & regenerative medicines, as well as nutritional supplement businesses.
juvlabs.com
Stage
Seed, Series A
juvlabs.com
Sectors
Healthcare, AI, Deeptech
juvlabs.com
Based
Douglas, IM
juvlabs.com
Sources
2026-09-03ichorlifesciences.comJuvenescence Limited is an investment company focused on therapies to increase human longevity…
2026-09-03juvlabs.comJuvenescence is a clinical-stage drug development company dedicated to extending healthy…
2026-09-03natlawreview.comIn addition, Juvenescence has investments in a number of cutting-edge companies and platform…
2026-09-03juvlabs.comJuvenescence will provide BYOMass with up to $6.5 million in equity financing and collaborate…
2026-09-03apis.ioJuvenescence Limited is a clinical-stage, AI-enabled drug development company headquartered in…
Portfolio, cheque size and the rest
The 12 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.